Trailing-twelve-month (TTM) revenue is $4.00 Billion with a year-over-year growth of (0.74%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-27 | $1,004,852,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q4 FY2025Period ended 2025-12-27 | $994,227,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-18 |
| Q1 FY2026Period ended 2026-03-28 | $995,830,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-27 | $1,004,078,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $3,998,987,000 |
Current P/S: $13,163,269,056 market capitalization ÷ $3,998,987,000 TTM revenue = 3.29x.
Market capitalization source: FMP quote. Quote observed 2026-09-10T16:05:17.000Z. Latest revenue period ended 2026-06-27.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-27): $1.00B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-10T16:05:17.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-27 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-27 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-26 · USD | FY20212021-12-25 · USD | FY20222022-12-31 · USD | FY20232023-12-30 · USD | FY20242024-12-28 · USD | FY20252025-12-27 · USD |
|---|---|---|---|---|---|---|
| Discovery and Safety Assessment | $1.8B | $2.1B | $2.4B | $2.6B | $2.5B | $2.4B |
| Manufacturing Support | $515M | $742M | $790M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-26 · USD | FY20212021-12-25 · USD | FY20222022-12-31 · USD | FY20232023-12-30 · USD | FY20242024-12-28 · USD | FY20252025-12-27 · USD |
|---|---|---|---|---|---|---|
| Asia Pacific | N/A | $223M | $193M | $201M | $197M | $205M |
| CANADA | $306M | $339M | $399M | $487M |
$4.00B
$4.00 Billion
(0.74%)
vs. $4.03B a year ago (TTM)
+4.08%
5 Year compound annual growth rate
1 Year
(0.74%)
3 Year
(0.70%)
5 Year
+4.08%
10 Year
+10.36%
15 Year
+8.86%
20 Year
+6.43%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $4.02B | ($34.61M) | (0.85%) |
| 2024 | $4.05B | ($79.42M) | (1.92%) |
| 2023 | $4.13B | +$153.35M | +3.86% |
| 2022 | $3.98B | +$435.90M | +12.31% |
| 2021 | $3.54B | +$616.23M | +21.08% |
| 2020 |
TTM Growth
(0.74%)
3-Year CAGR
(0.70%)
5-Year CAGR
+4.08%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-10T16:05:17.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $769M |
| $766M |
| Research Models and Services | $571M | $690M | $739M | $792M | $829M | $846M |
|---|
| $482M |
| $501M |
| Europe | $829M | $1.0B | $1.0B | $1.1B | $1.1B | $1.1B |
|---|
| JAPAN | $155M | N/A | N/A | N/A | N/A | N/A |
|---|
| UNITED STATES | $1.6B | $1.9B | $2.3B | $2.3B | $2.2B | $2.1B |
|---|
| $2.92B |
| +$302.71M |
| +11.55% |
| 2019 | $2.62B | +$355.13M | +15.67% |
| 2018 | $2.27B | +$408.50M | +21.99% |
| 2017 | $1.86B | +$176.17M | +10.48% |
| 2016 | $1.68B | +$318.13M | +23.34% |
